Back to search

University of South Florida

An Eye Opener in Stroke: Mitochondrial Dysfunction and Stem Cell Repair in Stroke-induced Retinal Ischemia

Abstract

dc:description

Stoke is a leading cause of disability and mortality across the globe, making it a global health crisis. However, treatments for stroke remain limited with narrow therapeutic time window. Visual impairment negatively affects patients’ quality of life. During stroke, the disruption in blood flow might affect both brain and eye resulting in cerebral and retinal ischemia. Currently, there is a lack of treatment option that targets both cerebral and retinal ischemia. Ischemic stroke pathology is complex and multiphasic. The ischemic event is followed by a secondary cascade of inflammatory cytokines exacerbating the initial focal injury and expanding into the penumbra. In recent years, mitochondrial dysfunction has been identified as a hallmark pathological of ischemia and reperfusion injuries. This pathology is marked by an increase in oxidative stress and reduced oxidative phosphorylation. Investigations have begun to shine the spotlight on mitochondrial dysfunction as the key contributor in stroke pathology. The role of stem cells as a therapeutic option has been growing over the last decade, particularly in central nervous system disorders. However, the underlying therapeutic mechanisms of stem cell therapy remain elusive. In the present work, we investigated the role of mitochondrial dysfunction as a key mechanism of cell death in stroke-induce retinal ischemia and explored the therapeutic mechanism of stem cell to rescue the mitochondrial dysfunction. We demonstrated that retinal ischemia accompanied cerebral ischemia, causing cellular degeneration in the eye. We showed that mitochondrial dysfunction characterized by decreased mitochondrial function, altered mitochondrial network morphology, and imbalanced mitochondrial dynamics, altogether indicating that impaired mitochondria are a key contributor to ischemic cell death. Finally, we demonstrated that stem cell therapy is a potential treatment for retinal ischemia by rescuing mitochondrial dysfunction via transfer of healthy mitochondria to injured cells. The present work revealed that using stem cells to target mitochondrial dysfunction represents a potential therapy for cerebral and retinal ischemia and potentially for other CNS disorders with mitochondrial dysfunction as a rampant underlying pathology.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (Ph.D.)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Medical Sciences
Grantor
University of South Florida
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Nguyen, Hung Vu Thien
Contributors dc:contributor
  • Cesario V. Borlongan, Ph.D.
  • Jay B. Dean, Ph.D.
  • Toru Shimizu, Ph.D.
  • Chuanhai Cao, Ph.D.
  • Byeong Jake Cha, Ph.D.
  • Ken Arai, Ph.D.

Subjects

dc:subject × 5

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/8396

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Nguyen, Hung Vu Thien. An Eye Opener in Stroke: Mitochondrial Dysfunction and Stem Cell Repair in Stroke-induced Retinal Ischemia. Dissertation thesis, University of South Florida, 2019. https://digitalcommons.usf.edu/etd/8396